fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Study examines adverse effects of obesity medications

Written by | 22 Nov 2021

An essential part of obesity care is making sure treatments are safe for patients. Abdulrahman Alsuhibani, a doctoral student in the University of Cincinnati’s James L. Winkle College… read more.

Biologics for systemic juvenile idiopathic arthritis

Written by | 9 Nov 2021

New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that biologics were the most common initial treatment prescribed to treat systemic… read more.

New AI algorithm to improve brain stimulation devices to treat disease

Written by | 9 Sep 2021

For millions of people with epilepsy and movement disorders such as Parkinson’s disease, electrical stimulation of the brain already is widening treatment possibilities. In the future, electrical stimulation… read more.

WasteLog and PrepLog – new applications for rapid drug analysis

Written by | 24 Aug 2021

Customers quickly identified new applications for the DrugLog device and this led to the development of two new products – WasteLog and PrepLog. Pharmacolog AB CEO Mats Högberg… read more.

DrugLog – rapid quality control for compounded injections

Written by | 23 Aug 2021

DrugLog is a bench-top device that allows rapid verification of the identity and concentration of a drug in a prepared injection. Originally conceived for quality control of compounded,… read more.

EMA gives green light for 8 new medicines

Written by | 17 Jul 2021

The European Medicine Agency’s key decision-making committee on human medicines (CHMP), has recommended eight medicines for approval at its June meeting.  The Committee recommended granting a conditional marketing authorisation for Abecma… read more.

EMA reports big wins for small pharma

Written by | 16 Jul 2021

The success rate for marketing authorisation applications for small and medium-sized enterprises (SMEs) has doubled between 2016 and 2020, according to the European Medicines Agency (EMA). In 2016,… read more.

Stents inspired by paper-cutting art can deliver drugs to the GI tract

Written by | 1 Jul 2021

Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that… read more.

Triple-drug therapy safely cuts serious asthma flares

Written by | 25 May 2021

Researchers have found that the inclusion of a third drug to commonly used dual-drug inhalers can reduce asthma exacerbations and improve control over the disease in children, adolescents,… read more.

The problems with polypharmacy

Written by | 12 May 2021

Interview and article by Christine Clark Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually… read more.

EU gives green light for new medicines

Written by | 12 May 2021

Article written by Gary Finnegan. The European Medicines Agency’s (EMA) key committee, known as the CHMP, has recommended approval of eight medicines at its latest meeting. While the… read more.

EMA backs six new medicines

Written by | 14 Mar 2021

Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.